by European Public Health Alliance | Jul 8, 2021 | Opinion
The access to medicines debate in Europe is at a critical juncture. With the pandemic, all issues, old and new, suddenly find a place on the agenda. They range from the prices of medicines, the flexibility of regulatory standards, the quality of innovation, all the...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Undeniably, pharmaceutical companies’ power and influence have grown in the context of the current pandemic. The politicisation of pharmaceuticals is unprecedented. Pharma CEOs pick up the phone and talk directly to EU heads of state and governments. Companies are...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Guest article: Ella Weggen & Marianne Meijer, Global Health Advovates, Wemos TRIPS waiver, C-TAP, the use of compulsory licensing, donations through COVAX – various strategies have been proposed to increase global access to COVID-19 vaccines. One way or another,...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Guest article by Jaume Vidal, Senior Policy Advisor, Health Action International The COVID-19 pandemic, and the efforts of governments and international organisations to counter it, has laid bare the pre-existing contradictions and shortcomings in the current...
by European Public Health Alliance | Jun 2, 2021 | Opinion
By Dr. Luciano Potena, ESOT President-Elect; Devi Mey, Director of Business Development, European Society for Organ Transplantation Solid-organ transplantation (SOT) has developed from an experimental approach in the 20th century to become an established and practical...
by European Public Health Alliance | Jun 2, 2021 | Opinion
Chloe Lebbos, Vice President of European Affairs Elect ‘21/22 & Fatumata Seck, Policy Coordinator Elect ‘21/22, EPSA (European Pharmaceutical Students’ Association) @ChloeL_ANEPF @EPSA_Online Physical distancing and the unprecedented pressure on healthcare...
